Literature DB >> 6618861

Radioimmunoassayable myoglobinaemia and Duchenne carrier detection.

B Lucci, C Dotti, L Camellini.   

Abstract

1 case of Duchenne Muscular Dystrophy (DMD) definite carrier, 3 probable and 17 possible (all analytically positive: "possible +") carriers were classed as Group A, 23 DMD possible carriers (all analytically negative "possible") as Group B and 26 normal subjects as Controls. The three groups were subjected to serum myoglobin (MGB) radioimmunoassay. Since the differences between MGB levels of Group A vs. Controls and Group A vs. Group B were statistically significant, it is suggested that the determination of MGB should be included among the tests for DMD carrier detection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618861     DOI: 10.1007/bf02043909

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  8 in total

1.  Deformed erythrocytes in muscular dystrophies.

Authors:  E Grassi; B Lucci; C Marchini; S Ottonello; M Parma; R Reggiani; G L Rossi; J Tagliavini
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

2.  Incidence and prevalence rates of Duchenne muscular dystrophy in the Province of Reggio Emilia.

Authors:  B Lucci
Journal:  Acta Neurol (Napoli)       Date:  1979-10

3.  Potential of radioimmunoassay of myoglobin in amniotic fluid and serum in prenatal diagnosis of Duchenne muscular dystrophy.

Authors:  K N Hansen; A Lademann; B Nørgaard-Pedersen
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

4.  Carrier detection in Duchenne muscular dystropy.

Authors:  J Tagliavini; S Ottonello; E Grassi; C Marchini; G L Rossi; B Lucci; M Parma; R Reggiani
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

5.  Serum myoglobin in muscular dystrophy and carrier detection.

Authors:  L V Nicholson
Journal:  J Neurol Sci       Date:  1981-09       Impact factor: 3.181

6.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

7.  Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection.

Authors:  B T Adornato; L J Kagen; W K Engel
Journal:  Lancet       Date:  1978-09-02       Impact factor: 79.321

8.  The significance of the estimation of serum myoglobin in neuromuscular diseases.

Authors:  E A Hische; H J van der Helm
Journal:  J Neurol Sci       Date:  1979-10       Impact factor: 3.181

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.